We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$66.2M
AUM Growth
-$4.96M
Cap. Flow
-$354K
Cap. Flow %
-0.53%
Top 10 Hldgs %
43.96%
Holding
112
New
26
Increased
20
Reduced
20
Closed
42

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.62M
2
PFE icon
Pfizer
PFE
+$3.09M
3
GILD icon
Gilead Sciences
GILD
+$2.52M
4
UNH icon
UnitedHealth
UNH
+$2.44M
5
LLY icon
Eli Lilly
LLY
+$1.85M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$1.61M
2
THC icon
Tenet Healthcare
THC
+$1.3M
3
AAPL icon
Apple
AAPL
+$1.26M
4
BRCM
BROADCOM CORP CL-A
BRCM
+$1.13M
5
LBTYK icon
Liberty Global Class C
LBTYK
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 69%
2 Communication Services 5.62%
3 Financials 5.54%
4 Technology 4.38%
5 Consumer Discretionary 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$4.35M 6.57%
47,279
+305
+0.6% +$26.4K
HCA icon
2
HCA Healthcare
HCA
$90.5B
$3.6M 5.45%
46,572
+8,970
+24% +$794K
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$3.47M 5.25%
41,793
+12,427
+42% +$1.12M
UNH icon
4
UnitedHealth
UNH
$353B
$3.31M 5%
28,505
+20,353
+250% +$2.44M
AGN
5
DELISTED
Allergan plc
AGN
$3.2M 4.84%
+11,785
New +$3.62M
PFE icon
6
Pfizer
PFE
$159B
$2.87M 4.34%
+96,289
New +$3.09M
GILD icon
7
Gilead Sciences
GILD
$181B
$2.23M 3.37%
+22,683
New +$2.52M
EW icon
8
Edwards Lifesciences
EW
$52B
$2.16M 3.27%
91,212
-7,740
-8% -$187K
BMY icon
9
Bristol-Myers Squibb
BMY
$136B
$2.05M 3.1%
34,643
-1,499
-4% -$95.1K
LLY icon
10
Eli Lilly
LLY
$1.05T
$1.84M 2.78%
+21,964
New +$1.85M
TEVA icon
11
Teva Pharmaceuticals
TEVA
$42.5B
$1.71M 2.58%
30,192
+5,051
+20% +$328K
META icon
12
Meta Platforms (Facebook)
META
$1.47T
$1.62M 2.45%
18,039
+2,182
+14% +$200K
PANW icon
13
Palo Alto Networks
PANW
$303B
$1.53M 2.32%
53,460
+16,146
+43% +$476K
AET
14
DELISTED
Aetna Inc
AET
$1.52M 2.3%
13,890
-500
-3% -$57.8K
MDCO
15
DELISTED
Medicines Co
MDCO
$1.38M 2.09%
36,399
-1,111
-3% -$39K
UHS icon
16
Universal Health Services
UHS
$10.1B
$1.37M 2.07%
10,993
+1,005
+10% +$140K
VMC icon
17
Vulcan Materials
VMC
$35.6B
$1.37M 2.07%
15,344
-4,480
-23% -$417K
AER icon
18
AerCap
AER
$23.2B
$1.32M 2%
34,563
-14,621
-30% -$646K
HRTX icon
19
Heron Therapeutics
HRTX
$62M
$1.27M 1.92%
51,947
+22,542
+77% +$751K
NOW icon
20
ServiceNow
NOW
$150B
$1.14M 1.73%
82,320
+24,305
+42% +$363K
JAZZ icon
21
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.08M 1.63%
8,136
-777
-9% -$134K
BRCM
22
DELISTED
BROADCOM CORP CL-A
BRCM
$1.08M 1.63%
20,985
-22,025
-51% -$1.13M
HD icon
23
Home Depot
HD
$329B
$1M 1.52%
+8,695
New +$1.01M
MIC
24
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$984K 1.49%
13,177
-4,164
-24% -$332K
HOLX
25
DELISTED
Hologic
HOLX
$975K 1.47%
24,910
-8,492
-25% -$337K
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Partner Investment Management held 112 positions worth $66.2M, down 7% from $71.1M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Partner Investment Management's Q3 2015 filing shows 26 new, 20 increased, 20 reduced and 42 closed positions. Its largest new stake was Allergan plc: 11,785 shares worth $3.2M. The largest sale was Elevance Health, an estimated $1.61M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 57% a quarter earlier, followed by Communication Services and Financials.

  • Partner Investment Management's largest Q3 2015 buy was Allergan plc: 11,785 shares worth $3.2M.
  • Partner Investment Management added most to UnitedHealth in Q3 2015, an estimated $2.44M increase.
  • Partner Investment Management's biggest Q3 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $1.13M.
  • Partner Investment Management fully exited Elevance Health in Q3 2015, selling an estimated $1.61M.
  • Partner Investment Management's ten largest holdings make up 44% of its $66.2M portfolio in Q3 2015.
  • Partner Investment Management opened 26 new positions and closed 42 in Q3 2015.
  • Partner Investment Management's portfolio value fell 7% quarter-over-quarter to $66.2M.

Based on Partner Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.